Grace Accounts Payable vs Total Assets Analysis

GRCE Stock   3.45  0.08  2.37%   
Grace Therapeutics, financial indicator trend analysis is much more than just examining Grace Therapeutics, latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Grace Therapeutics, is a good investment. Please check the relationship between Grace Therapeutics, Accounts Payable and its Total Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Grace Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.

Accounts Payable vs Total Assets

Accounts Payable vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Grace Therapeutics, Accounts Payable account and Total Assets. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Grace Therapeutics,'s Accounts Payable and Total Assets is 0.82. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Assets in the same time period over historical financial statements of Grace Therapeutics,, assuming nothing else is changed. The correlation between historical values of Grace Therapeutics,'s Accounts Payable and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Grace Therapeutics, are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Accounts Payable i.e., Grace Therapeutics,'s Accounts Payable and Total Assets go up and down completely randomly.

Correlation Coefficient

0.82
Relationship DirectionPositive 
Relationship StrengthStrong

Accounts Payable

An accounting item on the balance sheet that represents Grace Therapeutics, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Grace Therapeutics, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Assets

Total assets refers to the total amount of Grace Therapeutics, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Grace Therapeutics, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Grace Therapeutics,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Grace Therapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Grace Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.The current year's Issuance Of Capital Stock is expected to grow to about 13.4 M, whereas Tax Provision is forecasted to decline to (1.9 M).

Grace Therapeutics, fundamental ratios Correlations

0.751.00.79-0.210.82-0.590.840.550.070.920.550.921.00.71-0.440.63-0.46-0.14
0.750.730.84-0.580.9-0.760.870.67-0.410.770.750.830.730.93-0.690.82-0.72-0.53
1.00.730.8-0.150.79-0.540.810.50.130.890.560.91.00.68-0.390.59-0.41-0.08
0.790.840.8-0.150.7-0.460.660.38-0.030.590.950.650.80.71-0.380.5-0.41-0.16
-0.21-0.58-0.15-0.15-0.720.91-0.7-0.90.94-0.51-0.11-0.54-0.15-0.790.95-0.890.940.98
0.820.90.790.7-0.72-0.931.00.89-0.50.920.520.950.790.97-0.850.95-0.87-0.66
-0.59-0.76-0.54-0.460.91-0.93-0.92-0.990.76-0.79-0.33-0.81-0.54-0.940.98-0.990.980.88
0.840.870.810.66-0.71.0-0.920.9-0.460.950.470.970.810.95-0.840.95-0.85-0.64
0.550.670.50.38-0.90.89-0.990.9-0.750.770.240.780.50.89-0.980.97-0.98-0.88
0.07-0.410.13-0.030.94-0.50.76-0.46-0.75-0.21-0.1-0.250.13-0.630.86-0.720.850.98
0.920.770.890.59-0.510.92-0.790.950.77-0.210.330.990.890.81-0.660.83-0.67-0.41
0.550.750.560.95-0.110.52-0.330.470.24-0.10.330.410.560.61-0.310.36-0.34-0.16
0.920.830.90.65-0.540.95-0.810.970.78-0.250.990.410.90.86-0.680.85-0.7-0.44
1.00.731.00.8-0.150.79-0.540.810.50.130.890.560.90.68-0.390.59-0.41-0.08
0.710.930.680.71-0.790.97-0.940.950.89-0.630.810.610.860.68-0.90.96-0.92-0.76
-0.44-0.69-0.39-0.380.95-0.850.98-0.84-0.980.86-0.66-0.31-0.68-0.39-0.9-0.961.00.95
0.630.820.590.5-0.890.95-0.990.950.97-0.720.830.360.850.590.96-0.96-0.96-0.84
-0.46-0.72-0.41-0.410.94-0.870.98-0.85-0.980.85-0.67-0.34-0.7-0.41-0.921.0-0.960.94
-0.14-0.53-0.08-0.160.98-0.660.88-0.64-0.880.98-0.41-0.16-0.44-0.08-0.760.95-0.840.94
Click cells to compare fundamentals

Grace Therapeutics, Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Grace Therapeutics, is a strong investment it is important to analyze Grace Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Grace Therapeutics,'s future performance. For an informed investment choice regarding Grace Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Grace Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Grace Therapeutics,. If investors know Grace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Grace Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Grace Therapeutics, is measured differently than its book value, which is the value of Grace that is recorded on the company's balance sheet. Investors also form their own opinion of Grace Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Grace Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Grace Therapeutics,'s market value can be influenced by many factors that don't directly affect Grace Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Grace Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Grace Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Grace Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.